Tiwari S, Li L, Riazi S, Halagappa VK, Ecelbarger CM. Sex differences in adaptive downregulation of pre-macula densa sodium transporters with ANG II infusion in mice. Am J Physiol Renal Physiol 298: F187-F195, 2010. First published November 4, 2009 doi:10.1152/ajprenal.00088.2009.-An increase in blood pressure (BP) due to angiotensin II (ANG II) infusion or other means is associated with adaptive pressure natriuresis due to reduced sodium reabsorption primarily in proximal tubule (PT) and thick ascending limb (TAL). We tested the hypothesis that male and female mice would show differential response to ANG II infusion with regard to the regulation of the protein abundance of sodium transporters in the PT and TAL and that these responses would be modulated by aging. Young (ϳ3 mo) and old (ϳ21 mo) male and female mice were infused with ANG II at 800 ng ⅐ kg body wt Ϫ1 ⅐ min Ϫ1 by osmotic minipump for 7 days or received a sham operation. ANG II increased mean arterial pressure (MAP), measured by radiotelemetry, significantly more in male mice of both ages (increased ϳ30 -40 mmHg), compared with females (increased ϳ15-25 mmHg). On day 1, MAP was also significantly increased in old mice, relative to young (P ϭ 0.01). ANG II infusion was associated with a significant decline in plasma testosterone (to Ͻ30% of control male) in male mice and rise in young female mice (to 478% of control female). No sex differences were found in the upregulation of the sodium hydrogen exchanger abundance on Western blots observed with ANG II infusion or the downregulation of the sodium phosphate cotransporter; however, aging did impact on some of these changes. Male mice (especially young) also had significantly reduced levels of the TAL bumetanidesensitive Na-K-2Cl cotransporter (to 60% of male control), while young females showed an increase (to 126% of female control) with ANG II infusion. These sex differences do not support impaired pressure natriuresis in male mice, but might reflect a greater need and attempt to mount an appropriately BP-metered natriuretic response by additional downregulation of TAL sodium reabsorption.
SUBCUTANEOUS INFUSION of high-dose ("pressor dose") angiotensin (ANG II) is a commonly employed model of hypertension (13, 17, 39) . The concomitant increase in blood pressure (BP) is associated with adaptive pressure natriuresis. Mechanistically, a large part of this involves downregulation of proximal tubule (PT) sodium reabsorption via retrieval or brush-border intercolation of major sodium reabsorptive proteins in the apical membrane (22, 40, 41) . These proteins include the sodium hydrogen exchanger (NHE3), which is responsible for around 60% of sodium reabsorption, in exchange for hydrogen, in the PT (38) , and the sodium phosphate cotransporter (NaPi-2 or Npt2a) (24) , which cotransports sodium and phosphate across the apical brush-border membrane.
There is also an important role for the Na-K-ATPase pump in generating a gradient for NaCl reabsorption in determining overall PT sodium reabsorption or the natriuretic response to a rise in BP. Na-K-ATPase activity has been demonstrated to be regulated in a biphasic manner in response to ANG II (2, 5) . At low doses (picomolar to nanomolar), ANG II enhances activity; while at high doses (nanomolar to micromolar), it decreases its activity. Sites more distal to the PT also contribute to the pressure-induced natriuresis. Klein et al. (21) demonstrated marked downregulation of total cell abundance of the thick ascending limb (TAL)-associated bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) with chronic high-dose ANG II infusion in rats.
The majority of the above studies were done in young male mice or rats. Whether sex or age differences exist in the regulation of PT and TAL sodium transporters during pressureinduced natriuresis is not known. It is known that female mice respond to ANG II infusion with a reduced rise in BP (39) . It is thus possible that they will have relatively reduced protein levels of these transporters making for more efficient natriuresis. Alternatively, they may have identically changed levels of PT and TAL sodium transporters if the sex difference in BP rise is caused by a mechanism independent of pressure natriuresis, e.g., peripheral vasoconstriction. This might also be the case if the pressure natriuresis is accomplished primarily by a means other than downregulation of transporter abundance, such as trafficking, so that transporter protein levels need not be adjusted. Finally, there is the possibility that sodium transporters will be decreased to a greater extent in the males, e.g., if BP is higher or the relative sodium-retaining actions of ANG II are more potent in the males. Relatively greater downregulation of transporters would thus reflect simply a metered adaptation to adjust for the higher BP or early sodium retention.
With aging, we would predict that sex differences might be attenuated if they were primarily the result of activational effects of sex steroids. Female C57Bl/6 mice have an estrus cycle 4 -5 days long, which begins at ϳ1.5 mo of age, diminishes in frequency by 9 mo of age, and ceases entirely somewhere between 11 and 16 mo of age (10, 25) . On the other hand, male mice are found to have high levels of testosterone even at 30 mo of age, although certain metabolites and/or biosynthetic intermediates (including dihydrotestosterone) of testosterone appear altered (7) .
Thus, in the current set of studies, we determine whether there are differences in the regulation of BP and sodium transporter whole cell abundance in the PT and TAL in response to ANG II infusion between young and old, male and female mice. Semiquantitative Western blotting was used to evaluate differences in whole kidney, outer medullary, and/or cortical homogenates for NHE3, NKCC2, NaPi-2, and the ␣-1 subunit of Na-K-ATPase.
MATERIALS AND METHODS
Animals and study design. Three studies were performed. For all studies, mice of a mixed genetic background (C57Bl/6 ϫ CBA ϫ 129) were obtained from our own breeding colony (Georgetown University). In study 1, male and female mice (3 mo of age) were anesthetized with isoflurane and either implanted with osmotic minipumps (Alzet, model 2002, Durect, Cupertino, CA) to infuse ANG II (800 ng ⅐ kg body wt Ϫ1 ⅐ min Ϫ1 ) or received sham surgeries (n ϭ 6/sex/treatment). ANG II was dissolved in sterile saline and obtained from Bachem (Torrance, CA). After surgeries, mice were singly housed for 7 days in microfilter top, plastic cages with a normal 12:12-h light-dark cycle according to protocols approved by the Georgetown Animal Care and Use Committee, an Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)-approved facility. Study 2 was identical to study 1, except that mice were 18 -24 mo of age (n ϭ 6/sex/treatment). In study 3, a third set of young and old, male and female mice (n ϭ 4 -8/group) were implanted with radiotelemetry devices to measure BP over the course of a 7-day infusion of ANG II. At completion of study 3, in the female mice, the intact right and left ovary and uteri were collected and weighed. In all three studies, pelleted chow (Rodent Diet 5001, LabDiet, Purina Mills, St. Louis, MO) and water were offered to mice ad libitum. Mice were euthanized by cardiac puncture and exsanguination under pentobarbital sodium anesthesia. Both kidneys were rapidly removed for further analyses.
Radiotelemetry BP determinations. BP was measured using radiotransmitters (Data Sciences). Mice were anesthetized with pentobarbital sodium and a ventral incision was made near the sternum. The pressure-sensitive tip of the catheter attached to the transmitter was inserted and secured in the carotid artery, while the transmitter body was placed in a pocket subcutaneously. Mice were housed singly and the cages were placed on top of radioreceivers. After a recovery time of 7 days, BP was recorded every 10 min using Data Sciences Acquisition Software (Data Sciences) as described previously (32, 33) .
Immunoblotting. Left kidneys from studies 1 and 2 were homogenized whole (saw-tooth generator, PowerGen 700, Fisher Scientific, Waltham, MA) and prepared as a whole cell homogenate for immunoblotting as previously described (8) . Right kidneys were dissected and prepared as cortex homogenate (CTXH; large tannish region) and inner stripe of the outer medulla homogenate (OMH; narrow brightred strip outside of white inner medulla) using small, curved scissors and razor blades to separate regions. Each region was prepared separately as a whole cell homogenate. Initially, Coomassie-stained "loading gels" were done to assess the quality of the protein by sharpness of the bands and to confirm equality of loading, as previously described (8, 9) . For immunoblotting, 2-30 g of protein from each sample were loaded into individual lanes of minigels of 7 or 10% polyacrylamide (precast, Bio-Rad, Hercules, CA). Blots were probed with our own polyclonal antibodies against NHE3, NaPi-2, and NKCC2. These antibodies were designed using sequences already published (18 -20, 23) and our antibodies recognized the major bands at the same molecular weights. We used a commercial monoclonal antibody against the ␣-1 subunit of Na-K-ATPase (Upstate Biotechnology, Lake Placid, NY).
Statistics. Data are presented as means Ϯ SE. Statistical significance was determined by ANOVA (for 3 or more groups) or unpaired t-test (2 groups) using Sigma Stat software (Chicago, IL). Two-and three-way ANOVA were used to evaluate the impact of the main effect variables: treatment, sex, and age. To compare two groups (in a set of 3 or more), we used one-way ANOVA or the Kruskal-Wallis ANOVA on ranks (when data were not normally distributed or variance was different between groups). These tests, if significant, were followed by a multiple comparisons test including Holm-Sidak (followed 1-way ANOVA) or Dunn's (followed Kruskal-Wallis). Results of multiple comparisons tests were indicated by letters "A," "B," and "C," etc. "A" was assigned to the highest mean and all other means not statistically different from that highest mean. That is, means with letters in common are not significantly different from each other, i.e., "A" is different from "B" but not "AB." P Ͻ 0.05 was considered significantly different for all analyses.
RESULTS

Mean arterial BP.
Mean arterial BP (MAP) measured in mice infused with ANG II (from study 3) is shown in Fig. 1 . Females had a blunted rise in BP compared with males. When data were combined (2-way repeated measures on days 1-7), there was no significant effect of age. However, when days were analyzed separately, on day 1 (only) there was a significant effect of age (P ϭ 0.01) with older mice having significantly higher MAP compared with younger mice. Thus, it appeared that younger mice had a slower rise in the BP response, but plateaued at approximately the same level as the older mice. The effect of "sex" (by 2-way ANOVA) was significant on each of the 7 days. No differences between groups were seen at baseline (before infusion). Overall, MAP rose in male mice by ϳ30 -40 mmHg and in female mice by ϳ15-25 mmHg.
Body and kidney weights and plasma NOx. Older and male mice were significantly heavier (by 3-way ANOVA, sex ϫ treatment ϫ age), as expected ( Fig. 2A) . One-way ANOVA performed on the young mice data showed increased body weight in males, regardless of treatment (indicated by the letter "A"). A similar trend existed in the old mice, but there were no differences between individual groups due to higher variability in body weights. ANG II infusion had no effect on body weight. Likewise, no differences were found for kidney weights normalized to body weight across groups (Fig. 2B) , although there was a trend for young females to have smaller kidneys even when corrected for body weight (P ϭ 0.068, 2-way ANOVA, sex ϫ treatment). Plasma NOx levels were Fig. 1 . Mean arterial blood pressure (MAP) in young and old male and female mice infused with ANG II for 7 days. BPs were recorded by radiotelemetry at 10-min intervals over the course of the day and average daily measurements were plotted. Male mice had significantly increased BP response to ANG II infusion on each day (2-way ANOVA, sex ϫ age) and when days 1-7 were combined (2-way repeated-measures ANOVA). Old mice had significantly higher MAP than young mice on day 1 of infusion only (P ϭ 0.01). "A" is significantly higher than "B" and "AB" is not different from "A" or "B," as determined by Dunn's multiple comparison tests following a significant 1-way ANOVA.
not different between the sexes in control mice; however, after ANG II infusion, young male mice had a 71% increase in circulating NOx levels, while young female mice showed a 42% reduction (Fig. 2C ). Old mice, overall, had higher levels of plasma NOx in the control state (ϳ20% higher than young mice); this increased further in both sexes with ANG II infusion. There were no sex differences in plasma NOx in the old mice. One-way ANOVA across all eight groups showed that young female mice infused with ANG II had significantly lower plasma NOx levels compared with all other groups of mice infused with ANG II, i.e., young male, and old female and male ("B" vs. "A").
Plasma testosterone and ovary/uterine weights. Plasma testosterone levels were much higher in males, as expected, thus evaluated separately for each sex by two-way ANOVA for the effects of treatment and age (Fig. 3, A and B) . Older male mice had significantly higher plasma testosterone levels than did the young male mice. In addition, ANG II infusion led to a marked reduction in mean plasma testosterone at both ages. In female mice, there was a significant interaction between age and treatment so that young females infused with ANG II actually showed a rise in serum testosterone levels, whereas old females did not. In fact, in the aged females, there was a slight reduction. One-way ANOVA indicated old male mice had significantly higher plasma testosterone than ANG II-infused young males ("A" vs. "B"); however, no differences between individual groups were found for female mice. We were unable to obtain reliable measures of plasma estradiol in these mice; however, we did measure ovary and uterine weights from young and old mice (after ANG II infusion) as an index of estradiol activity. The combined weights of ovary and uterus were as follows (in g): young females 0.131 Ϯ 0.023, and old females 0.076 Ϯ 0.006, P ϭ 0.047 by unpaired t-test.
NHE3 abundance is upregulated by ANG II infusion in cortex. In Fig. 4A , there are representative immunoblots of NHE3 in cortex and outer medullary homogenate samples from study 1 (young mice). In Fig. 4B , there is the densitometry summary (expressed as % of male controls). The cortical samples are enriched in PT cells and are representative of the regulation of NHE3 at this site, whereas the outer medullary samples are enriched in TAL cells and are representative of NHE3 in this cell type, although clearly some cross-over will occur. Two-way ANOVA statistics are shown below the graph, and results of a multiple comparison's test following a signif- Results of 2-way ANOVA (sex ϫ treatment) are given within the graphs. Significant (P Ͻ 0.05) factors are in BOLD. Letters above the bars indicate results of the Holm-Sidak or Dunn's multiple comparison tests following a significant 1-way ANOVA. Bars with letters in common are not significantly different from each other. In males, younger mice and mice infused with ANG II had significantly reduced testosterone levels. In females, there was a significant interaction in that ANG II increased testosterone in young but not old mice. icant one-way ANOVA are shown above the bars as letters. In the young mice, in the cortex, ANG II led to a significant increase in NHE3, regardless of sex, and there were no independent effects of sex. In contrast, in the outer medulla, there was a significant interaction between sex and treatment in that female mice had increased NHE3 levels, but only in the untreated state. The effects of sex and ANG II in the old mice (study 2) are shown in Fig. 4 , C and D. Similar to young mice, ANG II led to a significant increase in cortical NHE3 (by 2-way ANOVA). However, while there was no effect of ANG II on outer medullary NHE3 in young mice, in the old mice, ANG II treatment led to a significant reduction in NHE3 (by 2-way ANOVA); one-way ANOVA indicated that this effect was strongest in females ("A" vs. "B"). Furthermore, old female mice had significantly lower levels of both cortical and outer medullary NHE3 than did old male mice (by 2-way ANOVA).
NaPi-2 is downregulated by ANG II infusion in both sexes. In Fig. 5A , a representative immunoblot of NaPi-2 in whole kidney homogenates from study 1 (young mice) is shown. NaPi-2 is expressed only in the PT, thus the whole kidney homogenate is representative of PT regulation. NaPi-2 on immunoblots ran as a single (nonglycosylated) band at ϳ80 kDa and a series of glycosylated bands ϳ82-87 kDa. Separate densitometries were done for each band or band region (Fig.  5B ). Young female mice had significantly lower abundance of the 80-kDa band for NaPi-2, compared with young male mice, while ANG II infusion led to a marked reduction in the density of the glycosylated bands in both sexes. In contrast, in the old mice (Fig. 5, C and D) , there was a significant increase in the 80-kDa band, and a significant reduction in the glycosylated band in female relative to male mice. Furthemore, ANG II led to a significant reduction in both bands in the older mice.
NKCC2 is downregulated by ANG II but only in males. In Fig. 6A , a representative immunoblot of NKCC2 in whole kidney homogenates from study 1 (young mice) is shown. NKCC2 is expressed in the TAL and macula densa (MD), thus the whole kidney homogenate is representative of its regulation along the length of the TAL and in the MD. ANG II infusion resulted in a significant downregulation of band density for NKCC2 in young male mice (Fig. 6B) . Young female mice, in contrast, had a rise in NKCC2 abundance with ANG II infusion so that levels were no different than control males. A similar pattern was observed in the old mice (Fig. 6, C and D) ; however, it did not reach the level of significance.
Young females show increased ␣-1 subunit of Na-K-ATPase with ANG II infusion. In Fig. 7A , there are representative immunoblots of the ␣-1 subunit of Na-K-ATPase in cortex and outer medullary homogenates from study 1 (young mice). ␣-1 Na-KATPase ran as two band regions one at ϳ120 kDa and the other (a dimer) at ϳ100 kDa. Band regions were summed for densitometric analysis. Similar to NHE3, the CTXH and OMH are used to evaluate PT and TAL Na-K-ATPase levels, respectively. Both of these cell types express high levels of this energetic pump. In young females, ANG II infusion resulted in increased band density for ␣-1 Na-K-ATPase in both cortex and outer medullary homogenates ("A" vs. "AB" or "B" in Fig. 7B ). This increase was absent in young males or in old mice (Fig. 7, C and D) of either sex. Similar to NHE3, old females showed a significant decline in outer medullary ␣-1 Na-K-ATPase levels with ANG II infusion (Fig. 7D) . Cortical NHE3 was increased by ANG II infusion in both sexes in young and old mice. Old female mice had reduced cortical NHE3 relative to old males. Outer medullary NHE3 was increased in young control females relative to young control males, and decreased in old females, relative to old males, regardless of treatment.
DISCUSSION
An increase in renal perfusion pressure as a result of a rise in BP, for example in response to ANG II infusion, elicits renal mechanisms to reduce renal sodium reabsorption. One theory is that a rise in renal interstitial hydrostatic pressure signals to tubule cells to reduce sodium retention via increased nitric oxide (NO), prostaglandin E 2 , and kinin production (15) . These signals may be translated to changes in sodium transporter regulation. Both NO and prostaglandins have been demonstrated to affect PT and TAL sodium transporter activity, subcellular distribution, and/or whole cell protein levels (12, 26, 34) . This reduction in sodium reabsorption in the early part of the renal tubule shifts the sodium load to the distal tubule, where it can be excreted, especially if the renin-angiotensin-aldosterone system (RAAS) is suppressed. In the case of ANG II infusion, the RAAS is not suppressed and some of the NaCl may be reabsorbed distally. This, in combination with the potent vasoconstrictor actions of ANG II, results in elevated BP.
Males of a variety of species including humans have higher BP than females (27, 28) . Young male mice have also been demonstrated to have increased BP in response to ANG II infusion (39) . We confirmed this increased BP sensitivity in young male mice and extended it to show an even more rapid rise in both sexes with aging. However, BP stabilized to near the same level in the two ages with time. This sex differential response may be the result of more efficient pressure natriuresis in the females or alternatively due to reduced BP-elevating effects of the ANG II. For example, they might have a different response to the same infusion rate of ANG II due to differences in expression ratio of ANG II receptors (AT1 relative to AT2) or greater angiotensin-converting enzyme type 2 (ACE2) activity, an enzyme which converts ANG II to Ang 1-7 (a vasodilator). This would lead to less of a requirement to initiate pressure natriuresis, at least to the same degree. We found downregulation of NKCC2 in male but not female mice with ANG II; and in female mice, ANG II led to an increase in the abundance of the ␣-1 subunit of Na-K-ATPase, while in males it was unchanged. These protein changes are consistent with a greater attempt to reduce sodium reabsorption in the male mice, relative to the females. In addition, there were no sex differences in the downregulation of NaPi-2 or the upregulation of NHE3 with ANG II infusion (at least in young mice). Thus, we have no evidence to support greater natriuretic capability in young female mice.
However, it is clear that other forms of protein regulation need to be examined to obtain a complete picture of molecular mechanisms underlying PT and TAL pressure natriuresis including changes in subcellular distribution, especially of the PT proteins, and changes in phosphorylation state. In other animal models associated with pressure natriuresis, e.g., arterial constriction, NaPi-2 and NHE3 are internalized to the subapical vesicles to promote sodium delivery to the distal tubule where renin release is then inhibited (42) . The resulting reduction in ANG II apparently has a role in the second step in retrieval associated with NHE3 (22). NaPi-2 retrieval, in contrast, was shown not to be dependent on ANG II.
With regard to protein abundance changes in response to ANG II infusion, most were consistent with other published reports. Turban and colleagues (36) showed no change in NHE3, NaPi-2, or ␣-1 Na-K-ATPase abundance in rats infused with a much lower dose of ANG II (ϳ6 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) or in low-NaCl-fed rats treated with candesartan (AT1 receptor blocker). However, the same group of investigators reported a 125% increase in band density for NHE3 when ANG II was infused at a higher dose (ϳ20 ng/kg body wt) coupled to high-NaCl diet (37) . Differences between the two studies may result from a greater rise in BP in the second study. They (37) also showed decreased NKCC2 in the high-dose study, as did Klein et al. (21) using a very high dose of ANG II in male rats (500 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Many of the changes in transporter levels we observed are likely not due to direct effects of ANG II but rather due to signaling molecules released in response to the rise in BP. For example, NO (or cyclic GMP) has been demonstrated to downregulate NaPi-2 levels in the brush-border membrane (4) . In contrast, NHE3 whole cell abundance has been positively associated with NO. In agreement with this concept, Turban et al. (37) showed that the upregulation of NHE3 in aldosterone-escape rats (infused with aldosterone and fed high-NaCl diet) could be attenuated by cotreatment with the NO synthase (NOS) inhibitor N G -nitro-L-arginine methyl ester (L-NAME). They also showed decreased NKCC2 in the L-NAME-treated rats, suggesting overall that NO positively upregulates renal proteins levels of NKCC2 and NHE3. Thus, it seems plausible that NO, a signaling component associated with pressure natriuresis, is responsible for decreased protein levels of NaPi-2 and increased protein levels of NHE3 in the ANG II-infused mice of both sexes. The one sex difference in these particular responses was in the downregulation of NKCC2, a TAL protein, which did not occur in the female mice. In fact, female mice actually had increased NKCC2 with ANG II infusion. Taken together with the results of Turban et al. (37) , this suggests the possibility that the female mice may have greater NO available in the TAL, relative to males. Several studies support increased renal NO-generating ability in female rodent tissue, relative to males (28 -30) . We showed female rats fed a high-NaCl diet had increased cortical NOS activity and urinary NOx excretion compared with similarly fed male rats (29) . However, plasma NOx levels in our mice (Fig. 2C) did not fully support this conclusion. Young female ANG II-infused mice had the lowest plasma NOx levels compared with all other groups. In fact, they were the only group that showed a fall in plasma NOx after the infusion. Nonetheless, the relationship of plasma NOx to renal NO is not clear and additional studies are clearly warranted in this area.
With regard to the sex differential responses seen in ␣-1 Na-K-ATPase, we believe these may also support a greater attempt at pressure natriuresis in the males. Na-K-ATPase activity is regulated in a biphasic manner by ANG II infusion (2, 5) ; high levels of ANG II decrease and low levels increase its activity. Thus, it is possible that the PT in female mice is perceiving a relatively lower level of ANG II, because in these mice the abundance of ␣-1 Na-KATPase was increased. This again might be due to relatively increased ACE2 or ratio of AT2 to AT1 receptor activity in these female mice. This is supported by studies of Sampson et al. (31) who demonstrated increased renal ACE2 mRNA and AT2 receptor in the kidney of female, relative to male, rats infused with ANG II.
The discussion up to this point has been primarily in regard to the young mice. One of the findings of the current set of studies, in agreement with our hypothesis, was that some sex differences in transporter regulation in response to ANG II were blunted or abolished in the aged mice, e.g., we saw no interaction between sex and treatment for the changes in NKCC2 or ␣-1 Na-K-ATPase. However, new sex differences were apparent (generally independent of ANG II infusion) in NHE3 and NaPi-2 (proteins not differentially regulated in the young mice between the sexes). Old female mice had significantly lower levels of NHE3 in the cortex and outer medulla, and qualitative differences in banding patterns developed for NaPi-2, compared with their aged, male counterparts. NaPi-2 protein ran as two separate bands, a lower band (most likely nonglycosylated) at 80 kDa and a more diffuse ladder of bands between ϳ82 and 87 kDa (glycosylated). In young mice, no sex differences were observed for these two bands; however, in the aged mice, the ratio of the upper to the lower band was markedly different between the sexes (see Fig. 5C ). Regulation of NaPi-2 protein between the sexes or by sex steroids has not been previously reported. However, NaPi-2 in the kidney has been reported to decrease in aging rodents (1, 35) . Furthermore, age-associated differences in NaPi-2b (intestinal isoform) glycosylation have been reported and associated with functional differences in cotransport activity (3) . For other proteins such as NKCC2 or the urea transporter, UT-A1, we've found increased glycosylation associated with diuretic states (6, 11) . However, the mechanism underlying the noted differences in NaPi-2 is not clear. The fact that sex differences in transporter regulation were altered with aging might be a general aging phenomenon, or due to changes in the levels of the activating sex steroids, e.g., estradiol and testosterone. Plasma testosterone levels were actually significantly higher in old male mice relative to young confirming earlier reports that the levels of this steroid do not decline even in advanced age in mice (7) . ANG II infusion resulted in a significant decline in testosterone levels in the young and old male mice. We found no other reports of a similar phenomenon, although we found the decrease quite robust at both ages (ϳ74 -80% reduction on average). Low testosterone levels have been associated with obesity and metabolic syndrome in men (14, 43) . It is generally assumed that the low testosterone levels predisposed these men to these diseases; however, it is possible that low testosterone is also partly a result of these diseases which are often associated with activated RAAS. In contrast, ANG II infusion in the young (but not old) female mice led to a significant rise in circulating testosterone levels. Most testosterone in females is derived from the ovaries. Jensterle et al. (16) recently reported reduced circulating androgen levels in human female patients with polycystic ovarian syndrome treated with the AT1 receptor blocker, telmisartan. Unfortunately, we were not able to measure plasma estradiol levels in these mice. Measurement of plasma estradiol in mice is notoriously difficult even using tandem mass spectroscopy (personal communication with K. Sandberg, Georgetown University). However, it is likely that estradiol levels were lower (on average) in the aged female mice, since our aged mice at 18 -24 mo were well beyond the age in which estrus cycling is reported to cease in mice (11-16 mo) (10, 25) . Furthermore, we did find significantly lower uterine/ovary weights in aged relative to young female mice, suggesting some senescence of ovarian function.
In summary, we found significant differences in PT and TAL sodium transporter regulation due both to sex and age in mice in response to ANG II infusion. Male mice had a greater BP response to ANG II, regardless of age, and most changes found in the young male mice were consistent with a greater attempt at natriuresis, compared with young females, i.e., relatively greater downregulation of NKCC2 and no upregulation of ␣-1 Na-K-ATPase. These particular sex differences were abolished in the old mice. As a whole, these sex differences do not support impaired pressure natriuresis in male mice, but might reflect a greater need and attempt to mount an appropriately BP-metered natriuretic response.
